99%+ Purity 17a-Hydroxyprogesterone Caproate Powder
Product Details:
| 17a-Hydroxyprogesterone Caproate Powder Information | ||
| 17a-Hydroxyprogesterone Caproate Price | 100g | According to your needs |
| 500g | According to your needs | |
| 1000g | According to your needs | |
| Steroid packaging | Special stealth packaging through Customs | |
| Delivery time | About 7 days | |
| Shipping | EMS, Hongkong Post, DHL, TNT, Fedex | |
| Payment terms | WU, MG, Bitcoin, T/T | |
| Minimum order | 10g powder | |
99%+ Purity 17a-Hydroxyprogesterone Caproate Powder
17a-Hydroxyprogesterone Caproate Details:
Product Name: 17A-hydroxyprogesterone hexanoate
Synonym: Hydroxyprogesterone Caproate; 17alpha-Hydroxyprogesterone caproate; Hydroxy progesterone caproate; 17A-Hydroxyprogesterone Caproate
CAS: 630-56-8
EINECS Number: 211-138-8
Formula: C27H40O4
MW: 428.6041
Density: 1.1g / cm3
Melting point: 119 ℃
Boiling point: 536.4 ° C at 760 mmHg
Flash Point: 227.6 ° C
Vapor Pressure: 1.4E-11mmHg at 25 ° C
Usage: used progestin drugs
Assay: 99.3%
Appearance: White crystalline powder
17a-Hydroxyprogesterone Caproate Specifications:
COA
Items | Standard | Resutls |
Description | White or almost white crystalline powder, odorless | Conforms |
Solubility | insoluble in water, solube in ether, slightly soluble in benzene | Conforms |
Specific Optical Rotation | +58°---+64° (1% chloroform Solution) | 60.3° |
Melting Point | about 120 -124 ℃ | 123℃ |
Water | ≤0.1% | 0.05% |
Free N-Caproic Acid | ≤0.58% | 0.20% |
Ordinary Impurities | ≤2.0% | conforms |
Residual Solvents | Methanol ≤ 3000PPM | 1280PPM |
Ethanol≤5000PPM | 1500PPM | |
Dichloromethane ≤ 600PPM | 80PPM | |
Assay | 97.0%--103.0% | 99.30% |
17a-Hydroxyprogesterone Caproate Descriptions:
(1) 17α-Hydroxyprogesterone caproate is a synthetic steroid hormone that is similar to medroxyprogesterone acetate and megestrol acetate. It is an ester derivative of 17α-hydroxyprogesterone formed from caproic acid (hexanoic acid).
(2) 17α-Hydroxyprogesterone caproate was previously marketed under the trade name Delalutin by Squibb, which was approved by the U.S. Food and Drug Administration (FDA) in 1956 and withdrawn from marketing in 1999.
(3) The US FDA approved Makena from KV Pharmaceutical (previously named as Gestiva) on February 4, 2011 for prevention of preterm delivery in women with a history of preterm delivery, sparking a pricing controversy.
17a-Hydroxyprogesterone Caproate Usages:
(1) This medication is used in women who are pregnant with a single baby, and who have delivered a baby too early (preterm) in the past. It is used to help lower the risk of having a preterm baby again. Hydroxyprogesterone is a man-made form of a female hormone (progestin). It is not known how it works to prevent preterm labor.
(2) This medication is not intended to prevent preterm birth in women pregnant with more than one baby (such as twins, triplets). It is also not intended to stop active preterm labor.
